Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Geovax Labs GOVX

"Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. T

View modes: 

Seems like somethings up !!!!!

Speculation and nothing clear from reading other boards.   rate and reply


Hey again. Well that same lady is going to beat the krap out of me if I didn't buy soon. Lol she already slapping in the head with AVEO   rate and reply

Former Health Canada Senior Regulatory Compliance Officer joins Nextleaf

"The serious regulatory infractions by several large Canadian licensed cannabis producers, along with an expanded scope of cannabis products through legalization 2.0, reinforces the critical role that compliance oversight plays in building a cannabis company all stakeholders can be proud of," stated Paul Pedersen, co-founder and CEO of Nextleaf Solutions. "Sherry is more


Lol nice to see you here too.  I just took a position on this.  After the grant they got; I picked up a starter position.  Gonna hold it long term.  rate and reply


I'm looking at GOVX. I haven't pulled the trigger yet but 150 mill O/S, 6-7 mill market cap,  a mill in revenue, and what's crazy is Yahoo with a 1.50 target price. What do some more


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.